Cross-sectional evaluation of clinical parameters to select high prevalence populations for periodontal disease: the site comparative severity methodology

Abstract

Epidemiological studies have shown strong evidence that periodontal disease does not affect all subjects in the same manner. There are subjects and sites with higher risk for disease progression. This study tested parameters to select "a priori" sites and subjects potentially at risk. The data from periodontal clinical examinations of 2273 subjects was used. The clinical loss of attachment was measured in 6 sites per tooth. Using computer software, the patients were distributed into 14 age groups, with intervals of 5 years, from 11 years to greater than 75 years of age. The measure of each site was compared with the average and the median values of the subject age group, with the results indicating site comparative severity (SCS). Three global parameters were calculated: parameter 1 (P1)--percentage of sites with clinical attachment loss >or= 4 mm; parameter 2 (P2)--percentage of sites with clinical attachment loss >or= 7 mm; parameter 3 (P3)--percentage of sites with clinical attachment loss surpassing the median value for the age group by 100% or more. There were 1466 (65%) females and 807 (35%) males. Most subjects had P1, P2 and P3 values less than 30%. Parameter 3 allowed a division of the sample similar to that of Parameters 1 and 2, with the advantage of analyzing the subject in relation to his/her age group. It was suggested that the methodology of SCS is useful for selecting a population with a high disease prevalence, and that cut-off lines between 10% and 20% would be appropriate for using Parameter 3.

Sex Differences in Destructive Periodontal Disease: A Systematic Review

“…1). In the final screen, 24 studies were excluded (interreviewer agreement κ = 0.96) by full‐text evaluation and are described in Box 1 18‐41 …”

Occupational exposure to acid mists and periodontal attachment loss

“…Therefore, epidemiological studies have used PAL as the principal measure of the chronic irreversible stage of this disease 13,16,22 . Conclusions from this study need to be interpreted with caution because of several methodological limitations.…”

Nitrite and Nitrate Levels of Gingival Crevicular Fluid and Saliva in Subjects with Gingivitis and Chronic Periodontitis

“…In order to improve clinical management of periodontal patients, there is a need for the development of new diagnostic tests that can detect the presence of active disease, future disease progression, and evaluate the response to periodontal therapy. Advances in oral and periodontal diagnostic research are moving toward methods by which periodontal risk can be identified and quantified by objective measures such as biomarkers [6]. Biomarkers of disease play an important role in diagnosis, assessing the treatment outcomes, and drug discovery [7].…”